Novavax
NVAX
#5380
Rank
ยฃ1.19 B
Marketcap
ยฃ7.30
Share price
2.96%
Change (1 day)
46.43%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): ยฃ0.35 Billion

According to Novavax's latest financial reports the company's current earnings are ยฃ1.08 Billion. , an increase over its 2024 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.34 B-396.87%
2024 -ยฃ0.12 Billion-70.39%
2023 -ยฃ0.4 Billion-16.59%
2022 -ยฃ0.48 Billion-62.58%
2021 -ยฃ1.27 Billion320.54%
2020 -ยฃ0.31 Billion234.22%
2019 -ยฃ90.27 Million-30.17%
2018 -ยฃ0.13 Billion1.69%
2017 -ยฃ0.13 Billion-36.44%
2016 -ยฃ0.21 Billion70.4%
2015 -ยฃ0.12 Billion89.27%
2014 -ยฃ62.02 Million59.83%
2013 -ยฃ38.81 Million81.9%
2012 -ยฃ21.34 Million50.33%
2011 -ยฃ14.19 Million
2009 -ยฃ28.01 Million8.8%
2008 -ยฃ25.74 Million18.01%
2007 -ยฃ21.82 Million18.33%
2006 -ยฃ18.44 Million168.31%
2005 -ยฃ6.87 Million-62.51%
2004 -ยฃ18.33 Million52.4%
2003 -ยฃ12.03 Million-28.21%
2002 -ยฃ16.75 Million
2000 -ยฃ9.55 Million177%
1999 -ยฃ3.45 Million-11.54%
1998 -ยฃ3.9 Million10.64%
1997 -ยฃ3.53 Million-9.62%
1996 -ยฃ3.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ11.82 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.93 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.98 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ7.49 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ0.53 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ15.47 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ6.09 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.20 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA